MedDataX Logo

Hair Up Prospective Study

NCT ID: NCT03652701

Last Updated: 2019-04-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2019-04-01

Study Completion Date

2021-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to assess the performance of Hair Up on female pattern hair shedding and regrowth. 58 adult female patients suffering from hair loss will be evaluated in a single center prospective study

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss

NCT01451021

Androgenetic Alopecia Male Pattern Baldness Female Pattern Baldness
COMPLETED PHASE2

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002012)

NCT01451047

Androgenetic Alopecia Male Pattern Baldness Female Pattern Baldness
COMPLETED PHASE2

Treatment of Alopecic Scars by Follicular Unit Extraction Hair Transplantation

NCT06145672

Alopecia Scar
NOT_YET_RECRUITING NA

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)

NCT01451177

Androgenetic Alopecia Male Pattern Baldness Female Pattern Baldness
COMPLETED PHASE2

A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002899)

NCT01451112

Androgenetic Alopecia Male Pattern Baldness Female Pattern Baldness
COMPLETED PHASE2

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hair Loss

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Hair Up

Group Type EXPERIMENTAL

Hair Up

Intervention Type OTHER

Herbal topical

Placebo

Group Type PLACEBO_COMPARATOR

Placebo

Intervention Type OTHER

Placebo

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Hair Up

Herbal topical

Intervention Type OTHER

Placebo

Placebo

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Women who report hair loss during the past 3 months prior to the study

Exclusion Criteria

* Disorders and medications affecting hair loss/growth, pregnancy, scarring alopecia
Minimum Eligible Age

25 Years

Maximum Eligible Age

60 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shmuel Gonen Technologies Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLPR-001-0002

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004542)
NCT01451151 COMPLETED PHASE2
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0002013)
NCT01451073 COMPLETED PHASE2
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0005995)
NCT01451190 COMPLETED PHASE2
ENERGI-F701 for Female Hair Loss Treatment
NCT03351322 COMPLETED PHASE2
Prospective Study of Nutraceutical Supplements to Support Hair Growth in Females
NCT06376409 COMPLETED NA
Effect of PRP on the Therapy for Hair Growth
NCT02087319 COMPLETED NA
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004541)
NCT01451138 COMPLETED PHASE2
A Study to Evaluate and Compare Injections of Autologous Dermal Cells Into the Balding Scalp of Subjects With Hair Loss
NCT01451099 COMPLETED PHASE2
A Study to Evaluate and Compare Injections of Autologous Mixed Population of Dermal Cells Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0006931)
NCT01669746 COMPLETED PHASE2
Evaluation of an Oral Hair Supplement to Improve Hair Strength and Support Growth in Women and Men
NCT06362941 COMPLETED NA
Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss
NCT03662854 UNKNOWN PHASE1
Study to Determine Effect of Gentle Wounding to Stimulate Hair Follicle Neogenesis
NCT03491267 COMPLETED EARLY_PHASE1
Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females
NCT03052413 COMPLETED NA
A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.
NCT06515496 ACTIVE_NOT_RECRUITING NA
Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata
NCT02974868 COMPLETED PHASE2
PF-06651600 for the Treatment of Alopecia Areata
NCT03732807 COMPLETED PHASE2/PHASE3
Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia
NCT06218394 RECRUITING NA
Comparison Between Platelet Rich Plasma and Nanofat as an Adjuvant Therapy in HairTransplantation
NCT07287579 NOT_YET_RECRUITING NA
The Effect of Platelet-rich Plasma in Subjects With Androgenetic Alopecia
NCT03048461 WITHDRAWN PHASE2
Oral Nutraceutical Supplement With Standardized Botanicals in Males With Self-Perceived Thinning Hair and Loss
NCT03709563 TERMINATED NA
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004512)
NCT01451125 COMPLETED PHASE2
Oral Herbal Combination Formulation and Hair Growth in Women
NCT05019066 WITHDRAWN NA
A 6-month, Randomized, Double-blind, Placebo Controlled Study Evaluating the Efficacy and Safety of USPlus DERM to Promote Hair Growth in Men and Women With Self-perceived Thinning Hair.
NCT06920758 ACTIVE_NOT_RECRUITING NA
Successful Treatment of Female Pattern Hair Loss With Injection of Nanofat With and Without Platelet-Rich Plasma
NCT07096323 COMPLETED NA
Impact of a Topical Cosmetic Product on Women's Hair
NCT06060834 COMPLETED NA